slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.055
KRW
|
+2,75%
|
|
+9,31%
|
+13,04%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
759.328
|
553.292
|
869.255
|
457.391
|
139.497
|
154.649
|
Bedrijfswaarde
1 |
728.179
|
510.960
|
821.818
|
414.782
|
-15.580
|
22.956
|
K/w-verhouding
|
-51,9
x
|
-33,5
x
|
-48,9
x
|
-16,9
x
|
-5,24
x
|
-16,5
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
24,5
x
|
17,6
x
|
33,7
x
|
19,9
x
|
5,24
x
|
2,03
x
|
Bedrijfswaarde/omzet
|
23,5
x
|
16,2
x
|
31,8
x
|
18,1
x
|
-0,58
x
|
0,3
x
|
Bedrijfswaarde/EBITDA
|
-56,9
x
|
-35,3
x
|
-48,1
x
|
-22,2
x
|
1,27
x
|
-2,05
x
|
Bedrijfswaarde/FCF
|
-69,2
x
|
-42,8
x
|
-73,8
x
|
-18,4
x
|
0,48
x
|
-1,68
x
|
FCF Yield
|
-1,44%
|
-2,34%
|
-1,35%
|
-5,43%
|
209%
|
-59,4%
|
Price to Book
|
13
x
|
7,49
x
|
12
x
|
6,14
x
|
0,69
x
|
0,8
x
|
Aantal aandelen (in duizenden)
|
46.066
|
47.156
|
49.483
|
49.988
|
84.288
|
85.066
|
Referentieprijs
2 |
16.483
|
11.733
|
17.567
|
9.150
|
1.655
|
1.818
|
Datum van publicatie
|
14-03-19
|
11-03-20
|
23-03-21
|
23-03-22
|
21-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
31.034
|
31.469
|
25.818
|
22.975
|
26.638
|
76.039
|
EBITDA
1 |
-12.796
|
-14.456
|
-17.072
|
-18.643
|
-12.273
|
-11.221
|
Bedrijfsresultaat (EBIT)
1 |
-14.329
|
-16.402
|
-19.107
|
-20.754
|
-14.662
|
-14.733
|
Operationele Marge
|
-46,17%
|
-52,12%
|
-74,01%
|
-90,33%
|
-55,04%
|
-19,38%
|
Resultaat voor belastingen (EBT)
1 |
-14.281
|
-16.676
|
-19.232
|
-29.504
|
-25.581
|
-9.879
|
Nettowinst (verlies)
1 |
-14.420
|
-16.879
|
-17.507
|
-27.865
|
-25.093
|
-9.326
|
Nettomarge
|
-46,47%
|
-53,64%
|
-67,81%
|
-121,28%
|
-94,2%
|
-12,27%
|
WPA
2 |
-317,6
|
-350,3
|
-359,0
|
-540,0
|
-316,0
|
-110,0
|
Free Cash Flow
1 |
-10.517
|
-11.952
|
-11.130
|
-22.543
|
-32.617
|
-13.645
|
FCF-marge
|
-33,89%
|
-37,98%
|
-43,11%
|
-98,12%
|
-122,45%
|
-17,95%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
14-03-19
|
11-03-20
|
23-03-21
|
23-03-22
|
21-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
31.148
|
42.332
|
47.437
|
42.609
|
155.077
|
131.693
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-10.517
|
-11.952
|
-11.130
|
-22.543
|
-32.617
|
-13.645
|
ROE (netto-inkomsten/eigen vermogen)
|
-34,6%
|
-25,4%
|
-23,9%
|
-37,9%
|
-18,2%
|
-4,74%
|
ROA (netto-inkomsten/totale activa)
|
-17,2%
|
-13,5%
|
-11,4%
|
-10,1%
|
-4,81%
|
-4,01%
|
Totale activa
1 |
83.608
|
125.166
|
153.043
|
275.930
|
521.166
|
232.498
|
Nettoactief per aandeel
2 |
1.268
|
1.567
|
1.464
|
1.490
|
2.390
|
2.275
|
Cashflow per aandeel
2 |
77,70
|
48,50
|
37,50
|
55,70
|
91,20
|
182,0
|
Capex
1 |
3.617
|
2.832
|
2.836
|
5.818
|
7.957
|
2.248
|
Capex/omzet
|
11,65%
|
9%
|
10,98%
|
25,32%
|
29,87%
|
2,96%
|
Datum van publicatie
|
14-03-19
|
11-03-20
|
23-03-21
|
23-03-22
|
21-03-23
|
20-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +13,04% | 124 mln. | | +26,08% | 681 mld. | | +21,85% | 556 mld. | | -4,77% | 361 mld. | | +16,97% | 325 mld. | | +5,69% | 285 mld. | | +13,68% | 235 mld. | | +3,65% | 199 mld. | | -11,12% | 189 mld. | | -3,40% | 157 mld. |
Farmaceutische producten - Andere
|